REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS

被引：0
|
作者：
Schreiber, Stefan
Dignass, Axel
Peyrin-Biroulet, Laurent
Mosli, Mahmoud
Hather, Greg
Demuth, Dirk
Blake, Aimee
Curtis, Rebecca
Khalid, Javaria Mona
Loftus, Edward V., Jr.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 01期
关键词：
D O I：
10.1053/j.gastro.2017.11.205
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
p155
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [21] Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies
    Macaluso, Fabio Salvatore
    Ventimiglia, Marco
    Orlando, Ambrogio
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (08): : 1217 - 1227
  • [22] Effectiveness and safety of upadacitinib for inflammatory bowel disease: A systematic review and meta-analysis of RCT and real-world observational studies
    Zheng, Dian-yu
    Wang, Yi-nuo
    Huang, Yu-Hong
    Jiang, Min
    Dai, Cong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 126
  • [23] Real-world outcomes of vedolizumab for inflammatory bowel disease post liver transplantation
    Peverelle, M. a
    Mills, C.
    Testro, A.
    de Cruz, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S356 - S357
  • [24] Association of inflammatory bowel disease with the risk of Parkinson's disease: A meta-analysis of real-world evidence
    Hussain, Salman
    Najmi, Abul Kalam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 151 - 151
  • [25] Vedolizumab Achieves Corticosteroid-Free Clinical Response and Remission in Inflammatory Bowel Disease: A Real World Meta-Analysis
    Shaw, Caroline
    Brown, Rebecca
    Wang, Song
    Adsul, Shashi
    Agboton, Christian
    Kamble, Pravin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S345 - S345
  • [26] Systematic review and meta-analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease
    Bell, Conor
    Tandon, Parul
    Lentz, Eric
    Marshall, John K.
    Narula, Neeraj
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (10) : 2640 - 2648
  • [27] Safety and Efficacy of Vedolizumab in Elderly Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Dahiya, Dushyant S.
    Chandan, Saurabh
    Bapaye, Jay
    Mohan, Babu P.
    Ramai, Daryl
    Kassab, Lena L.
    Chandan, Ojasvini C.
    Dulai, Parambir S.
    Kochhar, Gursimran S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S627 - S627
  • [28] Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease
    Kotze, Paulo G.
    Ma, Christopher
    Almutairdi, Abdulelah
    Al-Darmaki, Ahmed
    Devlin, Shane M.
    Kaplan, GilaadG.
    Seow, Cynthia H.
    Novak, Kerri L.
    Lu, Cathy
    Ferraz, Jose G. P.
    Stewart, Michael J.
    Buresi, Michelle
    Jijon, Humberto
    Mathivanan, Meena
    Heatherington, Joan
    Martin, Marie-Louise
    Panaccione, Remo
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (06) : 626 - 637
  • [29] REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Raluy-Callado, Mireia
    Carroll, Robert
    Curtis, Rebecca
    Khalid, Javaria Mona
    Patel, Haridarshan
    GASTROENTEROLOGY, 2018, 154 (01) : S105 - S106
  • [30] Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting
    Kolehmainen, Sara
    Ylisaukko-Oja, Tero
    Jokelainen, Jari
    Koivusalo, Mirkka
    Jokiranta, T. Sakari
    Sipponen, Taina
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (08) : 906 - 913
12345